MODULATION OF MITOSIS BY ENHANCING THE INTERACTION OF CDC24A AND CYCLINB/CDK1
Details for Australian Patent Application No. 2003223926 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): 60/380,966 15.05.02 US
29 January 2004 Application Open to Public Inspection
Published as AU-A-2003223926
3 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
18 August 2005 Corrigenda
Applications OPI - Name Index Under the name ZEALAND PHARMA A/S, Application No. 2003223926, under INID (71) correct the name to read LUKAS, Jiri; ZEALAND PHARMA A/S
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003223927-Novel diazabicyclic biaryl derivatives
2003223925-STABILISED SOLID COMPOSITIONS OF MODIFIED FACTOR VII
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser